Clinical TechniqueLong-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)
Under a Creative Commons license
open archive
Key Words
Palifermin
GVHD
Hematopoietic stem cell transplantation
Cited by (0)
Copyright © 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.